Masayuki Amano

Scopus Author ID ResearcherID Researcher Name Resolver ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 12

Top Venues

Antimicrobial agents and chemotherapy

The Journal of infectious diseases

Proceedings of the National Academy of Sciences of the United States of America

RSC medicinal chemistry

Kumamoto University

Kumamoto University, Graduate School of Medical Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kumamoto University

Japan

Assistant professor :: Departments of hematology, collagen diseases, infectious diseases

Kumamoto University

Japan

Research Associate :: Departments of Hematology, collagen diseases, infectious diseases

Kumamoto National Hospital

Japan

Medical Doctor :: Gastroenterology

Amakusa Medical Center

Japan

Medical Doctor :: Internal Medicine

Kumamoto University Hospital Oct 01 2000 - Mar 31 2001

Japan

Medical Doctor :: Hematology and Infectious diseases

Kumamoto Red-Cross Hospital Apr 01 2000 - Sep 30 2000

Japan

Medical Doctor

Kumamoto University Hospital

Japan

Medical Doctor :: Hematology and Infectious diseases

Education History

Kumamoto University, Graduate School of Medical Science

Japan

PHD

Publications

Arun K Ghosh, Daniel Lee, Ashish Sharma, Megan E Johnson, Ajay K Ghosh, Yuan-Fang Wang, Johnson Agniswamy, Masayuki Amano, Shin-Ichiro Hattori, Irene T Weber, Hiroaki Mitsuya
Design of substituted tetrahydrofuran derivatives for HIV-1 protease inhibitors: synthesis, biological evaluation, and X-ray structural studies. Organic & biomolecular chemistry (2024)
Takuya Kobayakawa, Masayuki Amano, Miyuki Nakayama, Kohei Tsuji, Takahiro Ishii, Yutaro Miura, Kouki Shinohara, Kenichi Yamamoto, Masao Matsuoka, Hirokazu Tamamura
Development of anti-HBV agents targeting HBV capsid proteins. RSC medicinal chemistry 14 (10) (2023)
Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez, Hironori Hayashi, Kazuya Hasegawa, Cuthbert D Martyr, Arun K Ghosh, Hiroaki Mitsuya
Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors In Vitro . Antimicrobial agents and chemotherapy 66 (2) (2022)
Masayuki Amano, Sachiko Otsu, Yasuko Ichikawa, Nobuyo Higashi-Kuwata, Shuzo Matsushita, Shinya Shimada, Hiroaki Mitsuya
Restoration of neutralization activity against Omicrons BA.2 and BA.5 in older adults and individuals with risk factors following the 4th-dose of SARS-CoV-2 BNT162b2 vaccine. The Journal of infectious diseases (2022)
Masayuki Amano, Kenji Maeda, Kiyoto Tsuchiya, Shinya Shimada, Hiroaki Mitsuya
Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2-Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan. The Journal of infectious diseases 226 (11) (2022)
Travis Chia, Tomofumi Nakamura, Masayuki Amano, Nobutoki Takamune, Masao Matsuoka, Hirotomo Nakata
A Small Molecule, ACAi-028, with Anti-HIV-1 Activity Targets a Novel Hydrophobic Pocket on HIV-1 Capsid. Antimicrobial agents and chemotherapy 65 (10) (2021)
Guangyong Ma, Jun-Ichirou Yasunaga, Kazuya Shimura, Keiko Takemoto, Miho Watanabe, Masayuki Amano, Hirotomo Nakata, Benquan Liu, Xiaorui Zuo, Masao Matsuoka
Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence. Proceedings of the National Academy of Sciences of the United States of America 118 (17) (2021)
Tomofumi Nakamura, Teruya Nakamura, Masayuki Amano, Toshikazu Miyakawa, Yuriko Yamagata, Masao Matsuoka, Hirotomo Nakata
A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor. Journal of virology 94 (19) (2020)
Nao Nishimura, Mohamed Osman Radwan, Masayuki Amano, Shinya Endo, Eri Fujii, Hironori Hayashi, Shikiko Ueno, Niina Ueno, Hiro Tatetsu, Hiroyuki Hata, Yoshinari Okamoto, Masami Otsuka, Hiroaki Mitsuya, Masao Matsuoka, Yutaka Okuno
Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells. Cancer science 110 (10) (2019)
Masayuki Amano, Pedro Miguel Salcedo-Gómez, Ravikiran S Yedidi, Rui Zhao, Hironori Hayashi, Kazuya Hasegawa, Tomofumi Nakamura, Cuthbert D Martyr, Arun K Ghosh, Hiroaki Mitsuya
Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications. Antimicrobial agents and chemotherapy 63 (7) (2019)
Yuki Takamatsu, Manabu Aoki, Haydar Bulut, Debananda Das, Masayuki Amano, Venkata Reddy Sheri, Ladislau C Kovari, Hironori Hayashi, Nicole S Delino, Arun K Ghosh, Hiroaki Mitsuya
Novel Protease Inhibitors Containing C-5-Modified bis-Tetrahydrofuranylurethane and Aminobenzothiazole as P2 and P2' Ligands That Exert Potent Antiviral Activity against Highly Multidrug-Resistant HIV-1 with a High Genetic Barrier against the Emergence of Drug Resistance. Antimicrobial agents and chemotherapy 63 (8) (2019)
Masayuki Amano, Pedro Miguel Salcedo-Gómez, Rui Zhao, Ravikiran S Yedidi, Debananda Das, Haydar Bulut, Nicole S Delino, Venkata Reddy Sheri, Arun K Ghosh, Hiroaki Mitsuya
A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413. Antimicrobial agents and chemotherapy 60 (12) (2016)

Masayuki Amano.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masayuki Amano